Hutchmed China Limited Adr stock is traded at $14.20, with a volume of 93,088. It is up +2.01% in the last 24 hours and down -0.77% over the past month. HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Previous Close:
$13.92
Open:
$14.50
24h Volume:
93,088
Relative Volume:
1.98
Market Cap:
$2.47B
Revenue:
$549.97M
Net Income/Loss:
$458.86M
P/E Ratio:
5.41
EPS:
$2.62
Net Cash Flow:
-$89.06M
1W Performance:
+4.49%
1M Performance:
-0.77%
6M Performance:
+6.77%
1Y Performance:
-8.80%
1-Day Range:
$13.98$14.69
1-Week Range:
$13.02$14.69
52-Week Range:
$9.77$16.33
Hutchmed China Limited Adr Stock (HCM) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS